Top-News

Keryx Biopharmaceuticals News

Keine aktuellen Kursdaten verfügbar
WKN: 940772
ISIN: US4925151015
US-Symbol: KERX
Typ: Aktie

Keryx Biopharmaceuticals News

05.11.18 - PR Newswire
Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Keryx Biopharmaceuticals, Inc. In The U.S. District Court For The District Of Delaware
Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Keryx Biopharmaceuticals, Inc. In The U.S. District Court For The District Of Delaware PR ...
02.10.18 - PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Keryx Biopharmaceuticals, Inc. - KERX
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Keryx Biopharmaceuticals, Inc. - KERX PR Newswire
23.07.18 - PR Newswire
Wolf Popper LLP Investigates the Proposed Acquisition of Keryx Biopharmaceuticals, Inc. by Akebia Therapeutics, Inc.
Wolf Popper LLP Investigates the Proposed Acquisition of Keryx Biopharmaceuticals, Inc. by Akebia Therapeutics, Inc. PR Newswire
29.06.18 - PR Newswire
WeissLaw LLP Investigates Keryx Biopharmaceuticals Inc.
WeissLaw LLP Investigates Keryx Biopharmaceuticals Inc. PR Newswire
07.03.17 - PR Newswire
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Keryx Biopharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Keryx Biopharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
09.09.16 - PR Newswire
KERX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Keryx Biopharmaceuticals, Inc. and a Lead Plaintiff Deadline of October 3, 2016
KERX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Keryx Biopharmaceuticals, Inc. and a Lead Plaintiff Deadline of October 3, ...
08.09.16 - PR Newswire
INVESTOR ALERT: Rosen Law Firm Reminds Keryx Biopharmaceuticals Inc. Investors of Important October 3 Deadline in Class Action - KERX
INVESTOR ALERT: Rosen Law Firm Reminds Keryx Biopharmaceuticals Inc. Investors of Important October 3 Deadline in Class Action - KERX PR Newswire
06.09.16 - PR Newswire
Lifshitz & Miller Law Firm Announces Investigation of BBX Capital Corporation, Concordia International Corp., Corrections Corporation of America, Epiq Systems, Inc., Goldcorp Inc., Keryx Biopharma
Lifshitz & Miller Law Firm Announces Investigation of BBX Capital Corporation, Concordia International Corp., Corrections Corporation of America, Epiq Systems, Inc., Goldcorp Inc., ...
06.09.16 - PR Newswire
Lifshitz & Miller Law Firm Announces Investigation of BBX Capital Corporation, Concordia International Corp., Corrections Corporation of America, Epiq Systems, Inc., Goldcorp Inc., Keryx Biopharma
Lifshitz & Miller Law Firm Announces Investigation of BBX Capital Corporation, Concordia International Corp., Corrections Corporation of America, Epiq Systems, Inc., Goldcorp Inc., ...
26.08.16 - PR Newswire
Keryx Biopharmaceuticals, Inc. Sued By Block & Leviton For Violations Of The Federal Securities Laws
Keryx Biopharmaceuticals, Inc. Sued By Block & Leviton For Violations Of The Federal Securities Laws PR Newswire
12.08.16 - PR Newswire
KERYX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
KERYX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of ...
12.08.16 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - KERX
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and Upcoming ...
11.08.16 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Keryx Biopharmaceuticals Inc. (KERX) and Lead Plaintiff Deadline: October 3, 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Keryx Biopharmaceuticals Inc. (KERX) and Lead Plaintiff Deadline: October ...
09.08.16 - PR Newswire
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Keryx Biopharmaceuticals Inc.
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. PR Newswire
09.08.16 - PR Newswire
Block & Leviton LLP Announces The Filing Of A Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. For Violations Of The Federal Securities Laws
Block & Leviton LLP Announces The Filing Of A Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. For Violations Of The Federal Securities Laws PR Newswire
04.08.16 - PR Newswire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Keryx Biopharmaceuticals, Inc.
Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Keryx Biopharmaceuticals, Inc. PR Newswire
02.08.16 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keryx Biopharmaceuticals Inc. - KERX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keryx Biopharmaceuticals Inc. - KERX PR Newswire
02.08.16 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Keryx Biopharmaceuticals Inc. (KERX)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Keryx Biopharmaceuticals Inc. (KERX) PR Newswire
02.08.16 - PR Newswire
Keryx Biopharmaceuticals Inc. Investigated For Securities Fraud By Block & Leviton After Keryx Halts The Distribution Of Auryxia And Withdraws Its Full-Year Financial Forecast
Keryx Biopharmaceuticals Inc. Investigated For Securities Fraud By Block & Leviton After Keryx Halts The Distribution Of Auryxia And Withdraws Its Full-Year Financial Forecast PR ...
02.08.16 - PR Newswire
Wolf Popper LLP Announces Investigation of Fraud Claims on Behalf of Investors in Keryx Biopharmaceuticals, Inc.
Wolf Popper LLP Announces Investigation of Fraud Claims on Behalf of Investors in Keryx Biopharmaceuticals, Inc. PR Newswire

Newssuche

Videos

newspaper
24.04.24
Technical Trading: AUD/USD mit Mega Chance
AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »